Roche Not Ruling Out Creative Deals For ‘Tail End’ Brands
Executive Summary
A better value proposition and more in-tune marketing ideas would drive a more creative risk-sharing or asset swap-like arrangement for the oncology specialist’s more mature brands, says Roche CEO Severin Schwan.